Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Meta-analysis of prevalence.
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
Identification of Risk Factors for Falls in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla.
Residential Distance to High-voltage Power Lines and Risk of Neurodegenerative Diseases: a Danish Population-based Case-Control Study.
The effects of identification with a support group on the mental health of people with multiple sclerosis.
Protective Role of (RS )-glucoraphanin Bioactivated with Myrosinase in an Experimental Model of Multiple Sclerosis.
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Information provision for people with multiple sclerosis.
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Severe relapses under fingolimod treatment prescribed after natalizumab.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Employment as a health promotion intervention for persons with multiple sclerosis.
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.

Pages